T cells expressing anti-CD19 chimeric antigen receptors (CARs) have activity against chronic lymphocytic leukemia (CLL). but complete response rates range from 18% to 29%. so improvement is needed. Peripheral blood mononuclear cells (PBMCs) of CLL patients often contain high levels of CLL cells that can interfere with CAR T cell production. https://lecoureures.shop/product-category/mountaineering-homme-chaussures/